Conversely, some studies suggest that upregulation/overexpression of TFEB promotes degradation of Aß and tau aggregates, reduces cell apoptosis, and prevents memory impairment through autophagy-lysosome pathway in AD transgenic mice [38–40]. The gene discussed is MAPT; the disease is Alzheimer disease.